PSH:XETRA Sernova Corp

EUR 0.46 -0.03 -5.428571
Icon

Sernova Corp (PSH:XETRA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | XETRA
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 0.46

-0.03 (-5.43)%

EUR 0.24B

2.50K

N/A

N/A

Icon

PSH:XETRA

Sernova Corp (EUR)
COMMON STOCK | XETRA
EUR 0.46
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 0.24B

N/A

EUR 0.46

Sernova Corp (PSH:XETRA) Stock Forecast

N/A

Based on the Sernova Corp stock forecast from 0 analysts, the average analyst target price for Sernova Corp is not available over the next 12 months. Sernova Corp’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Sernova Corp is Bearish, which is based on 1 positive signals and 7 negative signals. At the last closing, Sernova Corp’s stock price was EUR 0.46. Sernova Corp’s stock price has changed by +15.97% over the past week, +25.58% over the past month and -28.10% over the last year.

No recent analyst target price found for Sernova Corp
No recent average analyst rating found for Sernova Corp

Company Overview Sernova Corp

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of ther...Read More

https://www.sernova.com

The Stiller Centre, London, ON, Canada, N6G 4X8

0

October

EUR

Germany

Adjusted Closing Price for Sernova Corp (PSH:XETRA)

Loading...

Unadjusted Closing Price for Sernova Corp (PSH:XETRA)

Loading...

Share Trading Volume for Sernova Corp Shares

Loading...

Compare Performance of Sernova Corp Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PSH:XETRA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Sernova Corp (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NOV:XETRA
Novo Nordisk A/S -2.48 (-2.15%) EUR498.47B 45.33 4.48

ETFs Containing PSH

Symbol Name PSH's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Sernova Corp (PSH:XETRA) Stock

Stock Target Advisor's fundamental analysis for Sernova Corp's stock is Bearish.

Unfortunately we do not have enough data on PSH:XETRA's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on PSH:XETRA's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on PSH:XETRA's stock to indicate if its overvalued.

The last closing price of PSH:XETRA's stock was EUR 0.46.

The most recent market capitalization for PSH:XETRA is EUR 0.24B.

Unfortunately we do not have enough analyst data on PSH:XETRA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Sernova Corp's stock.

As per our most recent records Sernova Corp has 0 Employees.

Sernova Corp's registered address is The Stiller Centre, London, ON, Canada, N6G 4X8. You can get more information about it from Sernova Corp's website at https://www.sernova.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...